The British pharmaceutical lobby is calling on the government. halt plans to increase rates of return on income (NYSE: ABBV)


Stock photo/E+ via Getty Images

A trade group representing the pharmaceutical industry pressured the British government on Thursday to drop plans to increase the rate of revenue repayment for drugmakers, arguing the move would harm innovation at a time when the sector is “already

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *